Axios Live: Health leaders emphasize AI progress with human oversight
AI is already accelerating drug development and predicting disease risk, but real-world applications still require human involvement and safety considerations
TL;DR
- AI is accelerating drug development and disease risk prediction.
- Human involvement and safety considerations are crucial for real-world AI applications in healthcare.
- AI-driven medical innovation should focus on curing disease and improving care.
- Some practitioners are hesitant about using AI tools in screenings, experiencing both fear and excitement.
- Boston is a strong incubator for health startups, but needs to work hard to stay ahead.
- Concerns exist about retaining scientific talent in the U.S. as the biotech industry grows.
- The FDA is reviewing how AI health care devices should be evaluated.
- Bayer sees AI opportunities in cell and gene therapy, precision oncology, cardiovascular health, and women's health.